HeartBeam, Inc. BEAT
0.40 USD +0.01 (+1.85%)
At closeNov 6, 2026, 6:11 PM EST
0.41 0.00 +1.12%
After hours · Nov 6, 6:11 PM ET
0.3815 Day range 0.4126
0.355 52-week range 4.00
- YTD
- -83.25%
- 1 year
- -75.19%
News
businesswire.com HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam to Host Third Quarter 2026 Results Conference Call on Thursday, November 12, 2026 at 4:30 p.m. Eastern Time.
businesswire.com HeartBeam Announces Positive Heart Attack Pilot Study Results at TCT 2026: Patient-Recorded 3D ECG Shown to Be as Accurate as Standard 12-Lead ECG SANTA CLARA, Calif.--(BUSINESS WIRE)--HeartBeam Announces Positive Heart Attack Pilot Study Results at TCT 2026: Patient-Recorded 3D ECG Shown to be as Accurate as Standard 12-Lead ECG.
benzinga.com HeartBeam Wins FDA Total Product Life Cycle Advisory Program Pilot Acceptance For Heart Attack Assessment Technology Acceptance into FDA’s TAP Pilot follows Breakthrough Device Designation granted earlier this month for HeartBeam’s heart attack assessment technologyTAP Pilot provides dedicated FDA advisors and…
benzinga.com HeartBeam Completes Enrollment Ahead Of Schedule In 486-Patient HEADSTART-ACS Study HEADSTART-ACS study conducted in collaboration with Indonesia’s National Cardiovascular Center in world’s fourth most populous country, representing strategically significant market of 288 million…
benzinga.com HeartBeam Named Contributing Partner In Launch Of EXIT-CVD Research Project, Co-Funded By European Union Innovative Health Initiative And Industry Partners HeartBeam joins Philips, Medtronic, GE HealthCare and other global healthcare leaders in the EU-funded EXIT-CVD research consortiumHeartBeam will lead the HEART-CHECK Study, one of the project’s 22…
benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session Gainers Jaguar Health (NASDAQ:JAGX) stock moved upwards by 34.0% to $6.34 during Tuesday's pre-market session. The company's market cap stands at $2.4 million. Option Care Health (NASDAQ:OPCH) stock…
benzinga.com HeartBeam Secures FDA Designation for At-Home Heart Attack Detection System HeartBeam secures an expedited FDA designation for its 3D ECG at-home heart attack assessment tool, paving the way for rapid clinical trials.
benzinga.com 12 Health Care Stocks Moving In Monday's Intraday Session Gainers HeartBeam (NASDAQ:BEAT) stock moved upwards by 70.5% to $0.74 during Monday's regular session. The market value of their outstanding shares is at $24.4 million. PDS Biotechnology…
benzinga.com Dow Gains 100 Points; ISM Services PMI Falls In September U.S. stocks rose Monday: Dow +0.2%, S&P 500 +0.62%, Nasdaq +0.84%. Materials led; ISM services PMI slipped to 54.9. Oil fell 1%.
benzinga.com US Stocks Mixed; Nasdaq Gains Over 50 Points U.S. stocks mixed: Nasdaq and S&P 500 rose while Dow dipped. Weak jobs data pressured outlook; oil fell, while gold, silver and copper gained.
benzinga.com HeartBeam Receives FDA Breakthrough Device Designation For Its HeartBeam System For Assessing Potential Heart Attacks At Home The designation recognizes the potential of HeartBeam’s 3D ECG technology, which captures the heart’s electrical signals from three non-coplanar dimensions, to enable physicians to evaluate signs of…- benzinga.com HeartBeam Enters ATM Equity Offering Agreement To Sell Up To $25M Of Common Stock Through Titan Partners Securities On August 14, 2026, HeartBeam, Inc. (the "Company"), entered into an At-The-Market Equity Offering Sales Agreement (the "Sales Agreement") with Titan Partners Securities LLC, as sales agent, pursuant…
- benzinga.com 12 Health Care Stocks Moving In Friday's Intraday Session Gainers MDxHealth (NASDAQ:MDXH) stock moved upwards by 120.8% to $1.02 during Friday's regular session. The company's market cap stands at $23.7 million. The company's, Q2 earnings came out yesterday.
benzinga.com HeartBeam Reports Q2 2026 Results: Full Earnings Call Transcript HeartBeam (NASDAQ:BEAT) held its second-quarter earnings conference call on Thursday. Below is the complete transcript from the call. Benzinga APIs provide real-time access to earnings call…- benzinga.com Maxim Group Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $2 Maxim Group analyst Anthony Vendetti initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy rating and announces Price Target of $2.
- benzinga.com HeartBeam Wins U.S. Patent Expanding ECG Device With Acoustic Sensing, Impedance Features For Heart Disease Monitoring Patent extends HeartBeam's ECG hardware platform with multi-modal sensing capabilitiesAcoustic sensors enable HeartBeam’s device to function as a "digital stethoscope" to assess heart valve…
benzinga.com HeartBeam Announces Reorganization To Prioritize Global Market Reach And Capital Efficiency While Accelerating Execution; To License Its 3D ECG Signal Technology To Established Partners Company will license its 3D ECG signal technology to established partners, moving beyond direct medical device salesAdvancing toward heart attack detection as a key expansion of the platformTailoring…
benzinga.com HeartBeam Publishes JACC Study Showing Its Credit Card‑Sized ECG Device Can Predict Heart Attack Risk In Chest Pain Patients Publication in JACC: Advances demonstrates that an algorithm combining the HeartBeam ECG device with patient risk factors and symptoms can accurately identify heart attack riskStudy advances the…- benzinga.com HC Wainwright & Co. Maintains Buy on HeartBeam, Lowers Price Target to $2.5 HC Wainwright & Co. analyst Yi Chen maintains HeartBeam (NASDAQ:BEAT) with a Buy and lowers the price target from $5.5 to $2.5.
- benzinga.com Benchmark Maintains Speculative Buy on HeartBeam, Lowers Price Target to $5 Benchmark analyst Bill Sutherland maintains HeartBeam (NASDAQ:BEAT) with a Speculative Buy and lowers the price target from $8 to $5.
benzinga.com HeartBeam Q1 2026 Earnings Call: Complete Transcript - benzinga.com HeartBeam Q1 EPS $(0.12) Beats $(0.14) Estimate HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.14) by 14.29 percent. This is a 33.33 percent increase over losses of $(0.18)…
benzinga.com Earnings Scheduled For May 13, 2026 - benzinga.com HeartBeam Initiates Pilot Study Of Its Novel 12-Lead ECG Patch In Patients With Suspected Coronary Artery Disease The study is being conducted at two leading hospitals in Belgrade, Serbia. The initiation of the pilot study represents a significant step in the development of the HeartBeam patch which has the…
benzinga.com HeartBeam Enters Commercial Agreement With Atelier Health To Expand The Company's Commercial Footprint Across Four Targeted Launch Markets Leading concierge practice Atelier Health, led by physicians affiliated with Cedars-Sinai, will now offer HeartBeam to its patientsOpens up flagship sites across New York, Dallas, South Florida and…- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why NN Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket NN Inc. (NNBR) rose in pre-market trading after announcing expected sales growth and raising full-year guidance. Other gainers include NICM, AGAE, IMMP, LIMN, CIIT, MLSS, LAES, GBR, and STNE. Losers…- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com B. Riley Securities Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $4 B. Riley Securities analyst Anderson Schock initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy rating and announces Price Target of $4.
benzinga.com This Honeywell Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Friday Wall Street analysts change outlook on top names. Check analyst ratings page for upgrades, downgrades, and initiations. See others' views on these stocks.- benzinga.com D. Boral Capital Initiates Coverage On HeartBeam with Buy Rating, Announces Price Target of $5 D. Boral Capital analyst Jason Kolbert initiates coverage on HeartBeam (NASDAQ:BEAT) with a Buy rating and announces Price Target of $5.
- benzinga.com HC Wainwright & Co. Reiterates Buy on HeartBeam, Maintains $5.5 Price Target HC Wainwright & Co. analyst Yi Chen reiterates HeartBeam (NASDAQ:BEAT) with a Buy and maintains $5.5 price target.
benzinga.com HeartBeam Q4 EPS $(0.14) Misses $(0.13) Estimate HeartBeam (NASDAQ:BEAT) reported quarterly losses of $(0.14) per share which missed the analyst consensus estimate of $(0.13) by 5.26 percent. This is a 22.22 percent increase over losses of $(0.18)…- benzinga.com Earnings Scheduled For March 12, 2026
benzinga.com Heartbeam Stock Jumps After AI Collaboration With Mount Sinai HeartBeam shares are trading higher Tuesday following a partnership with Mount Sinai to accelerate next-gen AI-ECG algorithms.- benzinga.com 12 Health Care Stocks Moving In Tuesday's Pre-Market Session
benzinga.com HeartBeam Teams Up With Mount Sinai To Develop AI Tools For Heart Monitoring HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced a strategic collaboration with the Icahn…- benzinga.com HeartBeam To Provide Demos Of Recently FDA-Cleared HeartBeam System; Team To Provide Demos Of Working Prototype 12-Lead ECG Extended Wear Patch To Physicians And Potential Industry Partners At ACC.26 HeartBeam, Inc. (NASDAQ:BEAT), a medical technology company focused on transforming cardiac care by providing powerful cardiac insights, today announced that management will attend key investor and…
- benzinga.com 12 Health Care Stocks Moving In Monday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
benzinga.com Why Aditxt Shares Are Trading Higher By Around 63%; Here Are 20 Stocks Moving Premarket - benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Thursday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's After-Market Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Intraday Session
- benzinga.com 12 Health Care Stocks Moving In Wednesday's Pre-Market Session
- benzinga.com 12 Health Care Stocks Moving In Tuesday's After-Market Session